TSE:MBX - Microbix Biosystems Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$0.26 +0.01 (+4.00 %) (As of 01/22/2019 03:29 AM ET)Previous CloseC$0.25Today's RangeC$0.26 - C$0.2652-Week RangeC$0.16 - C$0.34Volume43,000 shsAverage Volume48,991 shsMarket CapitalizationN/AP/E Ratio-2.89Dividend YieldN/ABetaN/A ProfileDiscussionChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Microbix Biosystems Inc. develops and commercializes biological and technology solutions for human health and wellbeing in North America, Europe, and internationally. It offers infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry; controls for diagnostic assays; basic and applied research in virology, microbiology, cell biology, immunology, and pathology; and for vaccine and antiviral research and development. The company also provides quality assessment products, including PROCEEDx Verification/Validation samples, which are research use only products for use in test system IQ/OQ/PQ, verification/validation, and training; PTDx proficiency testing products; and REDx Controls, which are designed to enhance the diagnostic quality outcome by early detection of the deviations from desired assay performance. In addition, it develops Kinlytic Urokinase for injection, a thrombolytic biologic drug used to treat blood clots; and LumiSort cell-sorting, a technology for sorting of particles that could be used to enrich cell populations of interest, such as in sexing semen. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. Receive MBX News and Ratings via Email Sign-up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange TSE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolTSE:MBX Previous Symbol CUSIPN/A Webmicrobix.com Phone+1-905-3618910Debt Debt-to-Equity Ratio60.45 Current Ratio1.46 Quick Ratio0.35Price-To-Earnings Trailing P/E Ratio-2.89 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$12.51 million Price / Sales2.02 Cash FlowC$0.00 per share Price / Cash Flow200.00 Book ValueC$0.11 per share Price / Book2.43Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares96,973,000Market CapC$0.00 OptionableNot Optionable Microbix Biosystems (TSE:MBX) Frequently Asked Questions What is Microbix Biosystems' stock symbol? Microbix Biosystems trades on the Toronto Stock Exchange (TSX) under the ticker symbol "MBX." When is Microbix Biosystems' next earnings date? Microbix Biosystems is scheduled to release their next quarterly earnings announcement on Wednesday, February 13th 2019. View Earnings Estimates for Microbix Biosystems. Has Microbix Biosystems been receiving favorable news coverage? News headlines about MBX stock have been trending very positive on Tuesday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Microbix Biosystems earned a media sentiment score of 3.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days. Who are some of Microbix Biosystems' key competitors? Some companies that are related to Microbix Biosystems include 22nd Century Group (XXII), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Actinogen Medical (ACW), Almirall (LBTSF), Altimmune (ALT), Ampio Pharmaceuticals (AMPE) and Ampliphi Biosciences (APHB). Who are Microbix Biosystems' key executives? Microbix Biosystems' management team includes the folowing people: Mr. William J. Gastle, Founder & Exec. ChairmanMr. Cameron Groome, Pres, CEO & DirectorMr. James S. Currie, Chief Financial OfficerMr. Philip Casselli, Sr. VP of Sales, Bus. Devel. & MarketingMr. Vaughn C. Embro-Pantalony, Exec. Director How do I buy shares of Microbix Biosystems? Shares of MBX and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Microbix Biosystems' stock price today? One share of MBX stock can currently be purchased for approximately C$0.26. What is Microbix Biosystems' official website? The official website for Microbix Biosystems is https://microbix.com/. How can I contact Microbix Biosystems? Microbix Biosystems' mailing address is 265 Watline Ave, MISSISSAUGA, ON L4Z 1P3, Canada. The company can be reached via phone at +1-905-3618910. MarketBeat Community Rating for Microbix Biosystems (TSE MBX)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 41 (Vote Outperform)Underperform Votes: 37 (Vote Underperform)Total Votes: 78MarketBeat's community ratings are surveys of what our community members think about Microbix Biosystems and other stocks. Vote "Outperform" if you believe MBX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/22/2019 by MarketBeat.com StaffFeatured Article: What are no-load funds?